Literature DB >> 6609812

Corticotropin-releasing factor (CRF) acts centrally to inhibit growth hormone secretion in the rat.

C Rivier, W Vale.   

Abstract

The intracerebroventricular administration of 0.15 and 1.5 nmol ovine corticotropin releasing factor ( oCRF ) to freely-moving adult male rats resulted in a dose-related inhibition of spontaneous GH secretion. This inhibition lasted for at least 3 h and was statistically significant at all time points. By contrast, the iv injection of 1.5 nmol oCRF was without effect. These results suggest that CRF can act within the central nervous system to interfere with spontaneous GH secretion.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6609812     DOI： 10.1210/endo-114-6-2409

Source DB:  PubMed          Journal:  Endocrinology        ISSN： 0013-7227            Impact factor:   4.736


  9 in total

1.  Effect of corticotropin releasing factor injected into the median eminence on growth hormone secretion in male rats.

Authors:  J Frias; E Ruiz; E Ortega
Journal:  Neurochem Res       Date:  1999-06       Impact factor: 3.996

2.  Gene-environment interactions, not neonatal growth hormone deficiency, time puberty in female rhesus monkeys.

Authors:  Mark E Wilson; Becky Kinkead
Journal:  Biol Reprod       Date:  2007-12-26       Impact factor: 4.285

3.  Effect of CRF injected into the median eminence on GH secretion in female rats under different steroid status.

Authors:  A Puertas; J Frias; E Ruiz; E Ortega
Journal:  Neurochem Res       Date:  1996-08       Impact factor: 3.996

4.  Ultrashort-loop positive feedback of corticotropin (ACTH)-releasing factor to enhance ACTH release in stress.

Authors:  N Ono; J C Bedran de Castro; S M McCann
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

Review 5.  Neuroendocrine regulation of human growth hormone secretion. Diagnostic and clinical applications.

Authors:  G Delitala; P Tomasi; R Virdis
Journal:  J Endocrinol Invest       Date:  1988-06       Impact factor: 4.256

Review 6.  Psychiatric implications of altered limbic-hypothalamic-pituitary-adrenocortical activity.

Authors:  F Holsboer
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

7.  Effects of intravenous and intraventricular injection of antisera directed against corticotropin-releasing factor on the secretion of anterior pituitary hormones.

Authors:  N Ono; W K Samson; J K McDonald; M D Lumpkin; J C Bedran de Castro; S M McCann
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

Review 8.  Tissue-specific actions of the metabolic hormones FGF15/19 and FGF21.

Authors:  Bryn M Owen; David J Mangelsdorf; Steven A Kliewer
Journal:  Trends Endocrinol Metab       Date:  2014-12-01       Impact factor: 12.015

9.  Exploring the roles of fecundity-related long non-coding RNAs and mRNAs in the adrenal glands of small-tailed Han Sheep.

Authors:  Qing Xia; Qiuling Li; Shangquan Gan; Xiaofei Guo; Xiaosheng Zhang; Jinlong Zhang; Mingxing Chu
Journal:  BMC Genet       Date:  2020-04-06       Impact factor: 2.797
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.